AMFGNN: an adaptive multi-view fusion graph neural network model for drug prediction
Cross-validation results across multiple datasets indicate that AMFGNN outperforms seven advanced drug-disease association prediction methods. Additionally, case studies on Hepatoblastoma, asthma and Alzheimer's disease further confirm the model's effectiveness and potential value in real-world applications.
Authors
- Guangnan Xing (ORCID: https://orcid.org/0000-0002-2507-9195)
- Xiaojing Chang
- Mengxian Yu (ORCID: https://orcid.org/0009-0008-2743-0912)
- Lian Duan (ORCID: https://orcid.org/0000-0001-8561-5212)
- He Fang (ORCID: https://orcid.org/0000-0001-9036-8092)
- Huixia Zhou
Institutions
- Chinese PLA General Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-04-28
- DOI
- https://doi.org/10.3389/fphar.2025.1543966
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- General Hospital of People’s Liberation Army